The Non-Financial Ledger: What the Numbers Cannot Measure

Imagine you are watching someone you love disappear. Their name first. Then yours. Then themselves. Alzheimer’s disease does that. And the people who get hurt most by Nerium’s fraud were not naive investors chasing yacht money. They were parents researching supplements for aging fathers. They were football coaches buying pills for teenagers they were responsible for. They were veterans and electricians and college students who had already had their brains rattled and were looking, desperately, for something that might protect what was left.

Nerium and Signum understood that desperation completely. It was not a side effect of their marketing strategy; it was the engine of it. When Signum’s representative stood in front of thousands of cheering Brand Partners at the 2015 GetReal Conference and said there is “nothing that works in the pharmaceutical industry for stopping the progression of Alzheimer’s disease,” he was not being helpful. He was pointing at a void in human medicine and saying: we have the answer. They did not have the answer. They had a coffee extract that had only ever been tested on rodents, and they had decided that human trials were too expensive to bother with.

Think about what it feels like to believe you found the thing that will protect your child from the brain damage they might carry for the rest of their life from playing the sport they love. Think about sharing that belief with your community, posting it on Facebook, sending private messages to friends whose parents have dementia. Many of these people were not cynical scammers. They were Brand Partners who had been told by the company, and by internal FAQs written by Signum’s own scientists, that the rodent studies were enough to prove it worked in humans. They repeated those claims at youth football practices and in church basements and in comment sections, because they believed them.

And then there are the Brand Partners themselves. The ones who spent $500 or $1,000 of money they did not have on a starter pack because a friend or family member told them this was their path to financial freedom. Half of them were gone within six months, which is roughly how long it takes to realize that almost nothing you can do as a BP produces enough income to offset what you are spending to remain a BP. The $30 monthly tech fee. The conference registration. The business cards. The auto-delivery of product you cannot sell. The average active BP was making $65 a year gross, before any of those costs. That is not a business opportunity. That is the structural extraction of money from people who were specifically targeted because they were in a position of economic vulnerability, and because social networks of trust — friendship, family, community — could be turned into a distribution channel.

For the people at the very bottom, there was no scenario in which things got better. The model was designed that way. High attrition was not a flaw; it was a feature. The faster people quit, the more new recruits had to be brought in, and the more those recruits would spend on their initial packs before they too figured out the math. The dignity lost — the conversations with family members who were asked to join, the social capital burned, the shame of admitting it did not work — none of that shows up in the FTC’s accounting of ill-gotten gains.

Legal Receipts: What They Said in Their Own Words

These are verbatim quotes from the FTC’s complaint, filed November 1, 2019. Every word below is from the public court record.

“…a lot of things you can’t say, we’ll talk about that later on, because all those things you can’t say – it does!” — Defendant Jeffrey Olson, CEO of Nerium, speaking to thousands of Brand Partners at the April 2015 GetReal Conference immediately after a Signum representative presented EHT. Source: FTC Complaint ¶67.

• This statement proves Olson knew regulatory limits existed on what health claims could legally be made about EHT, and deliberately told his sales force to disregard those limits.
• By saying it publicly, on stage, to thousands of BPs, Olson transformed a compliance violation into company culture: sell what you legally cannot claim.
• This is cited in Count I (Illegal Pyramid) and Count V (Means and Instrumentalities) of the FTC complaint as evidence that Defendants furnished BPs with the means to commit deceptive acts.

“Nerium ‘doesn’t care’ if the company is not authorized by the Canadian government to make certain claims because ‘the BPs will spread all the claims by word of mouth.'” — Signum’s Chief Science Officer, in a May 2015 email, as cited in FTC Complaint ¶64.

• This email proves that Signum’s own senior scientist understood the legal exposure and actively chose a strategy designed to exploit BPs as an unaccountable intermediary layer, insulating the company from direct liability while the unsubstantiated claims spread anyway.
• The “word of mouth” strategy was deliberate, documented, and implemented by the company’s top scientific officer, not by rogue salespeople acting outside company guidance.

“Some of the content is only on Signum’s website ‘on purpose’ because Nerium ‘cannot use/say [it] from reg[ulatory] standpoint.'” — Nerium’s marketing director, in an April 2015 email responding to a BP’s question about whether ME Sports website content would be copied into Nerium’s Digital Library. Source: FTC Complaint ¶63.

• This email proves the split between Signum’s website and Nerium’s official materials was an intentional regulatory workaround, not a coincidence.
• Nerium pointed BPs toward Signum’s site knowing that site contained the health claims Nerium’s own lawyers said it could not make directly.

“Goal is to build SEO [search engine optimization] for EHT so that there is buzz around EHT that will help their product launch.” — Signum’s Director of Communications, in an October 7, 2014 email to Defendants’ advertising agency, explaining Nerium’s objective in helping build Signum’s web presence before Nerium EHT even launched. Source: FTC Complaint ¶57.

• This email proves the coordination between Nerium and Signum on marketing EHT began at least six months before Nerium EHT officially launched, and that the ME Sports website was built, in part, as pre-launch infrastructure for Nerium’s product.
• It establishes that the two entities operated as a coordinated marketing enterprise from the beginning, which is why the FTC named Signum Biosciences and Signum Nutralogix as co-defendants in the pyramid scheme action.

“There’s a Princeton undergrad, his name’s Chuck, and he’s a star, star running back. Freshman year, he had a stroke and he couldn’t walk… And we were able to turn him on EHT and change his life.” — A Signum representative, speaking to thousands of BPs at Nerium’s September 2015 GetReal Conference, encouraging them to share these “success stories” from Signum’s Facebook page. Source: FTC Complaint ¶85.

• This statement proves Signum representatives were actively deploying individual anecdotal claims about stroke recovery at large-scale recruiting events, with no clinical evidence and no disclaimer that the product had never been tested in human trials.
• Sharing these stories was directly encouraged by a company official, to maximize their viral spread through the BP network, contradicting any claim by Defendants that they were merely passive observers of BPs spreading false claims.

“Awesome!” — Nerium’s Chief Marketing Officer, responding to an email from the company’s public relations firm noting that NFL player Steve Weatherford “did not mention EHT in [an MSNBC] interview” about the movie Concussion, but that he had included “why he takes EHT in his follow up and social media posts.” The Facebook post was shared at least 3,400 times. Source: FTC Complaint ¶84.

• This single-word reply proves that Nerium’s most senior marketing executive celebrated the organic spread of EHT claims through third-party celebrity posts, even when those posts were not subject to Nerium’s formal review process.
• A 3,400-share Facebook post linking EHT to concussion treatment was celebrated at the CMO level, establishing that Defendants’ stated commitment to “policing” BP claims was not reflected in the behavior of their own leadership.

Societal Impact Mapping

Public Health

The EHT supplement fraud caused direct, documented harm to the public’s ability to make informed health decisions in the context of some of the most serious and least-understood diseases in human medicine.

• Defendants made false claims that EHT could prevent, reduce the risk of, and treat Alzheimer’s disease, with zero human clinical trials to support that claim, targeting a public that had no approved pharmaceutical treatments for the disease and was actively searching for protective options.
• Defendants made false claims that EHT could prevent, reduce the risk of, and treat Parkinson’s disease, falsely invoking the credibility of the Michael J. Fox Foundation even after that organization sent a cease-and-desist letter. Defendants continued making endorsement claims after receiving that letter.
• Defendants marketed EHT as a concussion and CTE treatment to parents of youth athletes, coaches, football players, and veterans, targeting people with documented traumatic brain injuries who were in a particularly vulnerable position regarding their long-term neurological health.
• Signum previously approached pharmaceutical companies about distributing EHT. Those companies required human clinical trials before any health claims could be made. Signum rejected that pathway, choosing instead to use an untrained MLM sales force to spread unsubstantiated claims by word of mouth, deliberately bypassing the safeguards that exist to protect public health.
• Signum’s own scientists wrote internal FAQ documents teaching BPs to argue that rodent studies were sufficient proof that EHT worked in humans, training tens of thousands of salespeople to repeat a scientifically false claim to consumers facing serious health decisions.
• The FTC alleged that as of the date of the complaint, Nerium BPs were still actively making false health claims on social media, including claims that EHT “repairs” brain damage, “heals CTE,” and is “the only All natural brain health supplement that heals and repairs Neuronal integrity.”

Economic Inequality

The pyramid structure of Nerium’s business was designed in a way that guaranteed losses for the overwhelming majority of participants, while concentrating wealth at the top of the organization.

• More than 95% of Nerium BPs paid more to Nerium each month than they earned in commissions and bonuses. The average active BP earned a gross annual income of $65 from Nerium, before any product purchase or fee costs were deducted.
• BPs were required to spend at least $80 per month on auto-delivery products, or recruit customers spending $120 on auto-delivery, just to remain eligible for any compensation at all. This mandatory recurring spend meant the floor cost of participation was guaranteed to exceed income for the vast majority of BPs.
• In their first month, 70% of new BPs spent either $500 or $1,000 on starter packs. The complaint documents that purchases by BPs in their first three months regularly made up one-third to one-half of all BP purchasing volume, showing the business relied financially on front-loading losses onto new recruits before they quit.
• Less than 1% of active BPs averaged earnings of even $530 per month. Sustained at every month for a full year, that would still yield less than $6,400 in gross annual income, without accounting for self-employment taxes, health insurance, product purchases, conference fees, or business material costs that BPs were required to pay out of pocket as independent contractors.
• Nerium specifically targeted college students and young adults through its “Young Entrepreneur Program,” which featured income claims about paying off student loans quickly and “retiring” parents, marketing financial exploitation directly to people already in debt.
• Nerium’s “free Lexus” promotion was false. Nerium provided a $500 monthly check toward a lease only while a BP maintained a rank fewer than 2% ever reached, and BPs remained personally liable for the full lease payments even if the bonus stopped.
• The rewards structure concentrated approximately one-third of all company compensation in “Team Commissions” accessible only to higher ranks, meaning the structural design ensured the majority of value flowed upward to those who had recruited the most people, not to those who had sold the most product.

The “Cost of a Life” Metric

What Now? How to Push Back

Nerium has rebranded as Neora LLC and continues to operate. The FTC litigation was ongoing as of the filing date. Here is who holds power in this situation and what you can actually do.

The People Who Run This

• Jeffrey Olson, founder and CEO of Neora LLC (formerly Nerium International). Individually named as a defendant in the FTC complaint. Resides in Fort Lauderdale, Florida.
• Maxwell Stock, CEO of Signum Biosciences, Inc. Featured in promotional videos and GetReal Conferences. His father, Dr. Jeffry Stock, serves as Signum’s Chairman.
• The company’s current corporate mailing address as of the complaint filing: 4201 Spring Valley Rd., Suite 900, Farmers Branch, TX 75244.
• Signum Biosciences and Signum Nutralogix: 11 Deer Park Dr., Suite 202, Monmouth Junction, NJ 08852.

Regulatory Watchlist

• Federal Trade Commission (FTC): The agency that filed this complaint. Report pyramid scheme activity, false income claims, and unsubstantiated health supplement claims at ftc.gov/complaint. The FTC’s Bureau of Consumer Protection directly handles MLM and supplement fraud cases.
• Food and Drug Administration (FDA): The FDA regulates dietary supplement claims under DSHEA. A supplement claiming to treat or prevent Alzheimer’s, Parkinson’s, or concussions is making an unauthorized drug claim. Report to FDA MedWatch at fda.gov/safety/medwatch.
• State Attorneys General: Multi-level marketing operations that operate as pyramid schemes can be prosecuted under state consumer protection statutes in every state where BPs were recruited. File complaints in Texas and New Jersey, the states of primary operation, as well as your own state.
• Better Business Bureau (BBB): File formal complaints to create a documented public record for anyone researching Neora / Nerium before joining or purchasing products.

Grassroots and Mutual Aid

• If you lost money as a BP: Document all your purchases, fees, and earnings with receipts. The FTC’s complaint requests restitution and disgorgement of ill-gotten monies. Contact the FTC directly to register as an injured consumer. Court-ordered restitution programs often require consumers to come forward; your documentation matters.
• If you purchased Nerium EHT for health reasons: File a complaint with the FTC and the FDA. If you or a family member made medical decisions based on EHT’s false claims, speak with a consumer protection attorney about your options.
• Warn your networks: Nerium / Neora continues to recruit. Share factual, source-linked information when you see Neora recruitment posts targeting vulnerable communities, college students, and young parents on social media. The FTC complaint is a public document and freely linkable.
• Support anti-MLM organizing: Organizations like the Coalition for MLM Awareness and advocacy communities that document income disclosure statements work to give potential recruits accurate financial data before they commit. Amplify their work.
• Financial mutual aid for affected BPs: People who lost significant money in Nerium are disproportionately likely to be in financial distress. Local mutual aid networks, community emergency funds, and financial counseling services through nonprofits like the National Foundation for Credit Counseling (NFCC) are available in most regions.